Cévní chirurgie UL s.r.o.

The site focuses on Skin and Connective Tissue Diseases, specifically chronic venous leg ulcers that fail to heal with conventional care.

• Evaluation of a topical stem‑cell formulation for promoting complete wound closure
• Comparison of a novel gel therapy with non‑surgical standard of care
• Safety monitoring of therapy‑resistant ulcer treatments

Participants receive careful follow‑up to assess healing progress and any adverse events, aiming to improve outcomes for patients with long‑standing ulcers.

Clinical investigations at Cévní chirurgie UL s.r.o. target the effectiveness of new biologics and gels for Venous Leg Ulcer (VLU) management.

• Assessment of an allo‑APZ2‑CVU biologic applied topically to chronic wounds
• Placebo‑controlled study of the EscharEx gel formulation
• Evaluation of outcomes against standard non‑surgical care protocols

The trials aim to establish safer, more effective options for patients whose ulcers have not responded to existing treatments.